Three cases of adult-onset Brown-Vialetto-Van Laere syndrome: Novel variants in SLC52A3 gene and MRI abnormalities.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
08 2021
Historique:
received: 04 08 2020
revised: 15 06 2021
accepted: 21 06 2021
pubmed: 14 8 2021
medline: 21 12 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

Brown-Vialetto-Van Laere syndrome is a rare, autosomal, recessive neurological condition caused by variants in the riboflavin transporter genes SLC52A2 and SLC52A3. Here, we report on three cases. Case 1 was a 35-year-old woman from a consanguineous family who presented with progressive deafness, subacute multiple cranial nerve impairments (III, VII, IX, XII), and MRI abnormalities (including as hypersignal from the cranial nerves). The patient was homozygous for a novel SLC52A3variant. Case 2 was the woman's brother, who presented similar symptoms. Case 3 was an 18-year-old woman experiencing progressive hearing loss, bilateral steppage gait and a cranial nerves impairment (VII and XII). MRI revealed hypersignal in the root nerves and cauda equina. A novel heterozygous variant in SLC52A3 was identified. A subacute history of polyradiculoneuropathy along with progressive deafness, cranial nerve impairment, and MRI abnormalities should raise suspicion for Brown-Vialetto-Van Laere syndrome.

Identifiants

pubmed: 34384672
pii: S0960-8966(21)00163-2
doi: 10.1016/j.nmd.2021.06.009
pii:
doi:

Substances chimiques

Membrane Transport Proteins 0
SLC52A3 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

752-755

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Guillaume Carey (G)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Neurology Department, Lille University Medical Center, Lille, France. Electronic address: guillaume.carey.etu@univ-lille.fr.

Gregory Kuchcinski (G)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Neuroradiology Department, Lille University Medical Center, Lille, France.

Fanny Gauvrit (F)

ENT Department, Lille University Medical Center, Lille, France.

Luc Defebvre (L)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Neurology Department, Lille University Medical Center, Lille, France.

Sylvie Nguyen (S)

Centre de référence des maladies neuromusculaires Nord Est Ile de France, Lille University Medical Centre, Lille, France; Neuropediatric Department, Lille University Medical Center, Lille, France.

Claire-Marie Dhaenens (CM)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.

Anne Frédérique Dessein (AF)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.

Christine Vianey-Saban (C)

Service de Biochimie et Biologie Moléculaire, UF Maladies Héréditaires du Métabolisme, Hospices Civils de Lyon, Bron, France.

Cécile Acquaviva (C)

Service de Biochimie et Biologie Moléculaire, UF Maladies Héréditaires du Métabolisme, Hospices Civils de Lyon, Bron, France.

Céline Tard (C)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Centre de référence des maladies neuromusculaires Nord Est Ile de France, Lille University Medical Centre, Lille, France; Neurology Department, Lille University Medical Center, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH